Incyte (INCY) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $3.09
- EPS estimate
- $2.20
- EPS surprise
- +40.72%
- Revenue surprise
- +11.92%
- Revenue
- $1.7B
- Revenue estimate
- $1.5B
- Reported
- Jul 28, 2026
Incyte reported Q2 2026 results on July 28, 2026. Earnings per share came in at $3.09, ahead of the $2.20 estimate by 40.72%. Revenue was $1.7 billion against a $1.5 billion consensus. Compared with Q2 2025, EPS nearly doubled from $1.57, and revenue grew from $1.2 billion. Both EPS and revenue were the highest in the table.
The longer record is uneven for earnings but steady for sales. Annual EPS was $1.52 in 2022, $3.16 in 2023 and $1.32 in 2024, then jumped to $6.79 in 2025. The 2024 total includes a loss of $1.82 per share in Q2 2024, the only losing quarter in the table. Annual revenue rose every year, from $3.39 billion in 2022 to $5.20 billion in 2025. The first half of 2026 adds up to $4.90 per share, about 80% more than a year earlier. Over the last 20 quarters, Incyte beat the EPS estimate 11 times and missed 9 times, often by wide margins.
Incyte reported Q3 between October 28 and November 2 in each of the past five years. That points to late October or early November 2026 for the next report. It will be compared with Q3 2025's $2.26 per share.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 28, 2026 | $2.20 | $3.09 | +40.72% | $1.7B | SEC |
| Q1 2026 | Apr 28, 2026 | $1.32 | $1.81 | +37.56% | $1.3B | SEC |
| Q4 2025 | Feb 10, 2026 | $1.91 | $1.80 | −5.53% | $1.5B | SEC |
| Q3 2025 | Oct 28, 2025 | $1.61 | $2.26 | +40.71% | $1.4B | SEC |
| Q2 2025 | Jul 29, 2025 | $1.42 | $1.57 | +10.83% | $1.2B | SEC |
| Q1 2025 | Apr 29, 2025 | $0.99 | $1.16 | +16.66% | $1.1B | SEC |
| Q4 2024 | Feb 10, 2025 | $1.50 | $1.43 | −5.06% | $1.2B | SEC |
| Q3 2024 | Oct 29, 2024 | $1.05 | $1.07 | +1.79% | $1.1B | SEC |
| Q2 2024 | Jul 30, 2024 | $0.75 | −$1.82 | −343.09% | $1.0B | SEC |
| Q1 2024 | Apr 30, 2024 | $0.78 | $0.64 | −17.81% | $880.9M | SEC |
| Q4 2023 | Feb 13, 2024 | $1.15 | $1.06 | −7.85% | $1.0B | SEC |
| Q3 2023 | Oct 31, 2023 | $0.83 | $1.10 | +31.93% | $919.0M | SEC |
| Q2 2023 | Aug 1, 2023 | $0.70 | $0.90 | +29.31% | $954.6M | SEC |
| Q1 2023 | May 2, 2023 | $0.56 | $0.10 | −82.14% | $808.7M | SEC |
| Q4 2022 | Feb 7, 2023 | $0.30 | $0.13 | −56.67% | $926.7M | SEC |
| Q3 2022 | Nov 1, 2022 | $0.50 | $0.50 | −0.71% | $823.3M | SEC |
| Q2 2022 | Aug 2, 2022 | $0.56 | $0.72 | +28.39% | $911.4M | SEC |
| Q1 2022 | May 3, 2022 | $0.46 | $0.17 | −62.72% | $733.2M | SEC |
| Q4 2021 | Feb 8, 2022 | $0.56 | $2.54 | +352.68% | $862.9M | SEC |
| Q3 2021 | Nov 2, 2021 | $0.58 | $0.82 | +40.87% | $813.0M | SEC |
Quarterly revenue
Frequently asked questions
When did Incyte (INCY) last report earnings?
Incyte last reported on Jul 28, 2026, covering fiscal Q2 2026.
Did INCY beat earnings estimates?
Yes. Incyte reported EPS of $3.09 for Q2 2026 against a $2.20 estimate — a 40.72% beat.
How much revenue did INCY report last quarter?
Incyte reported $1.7B in revenue for Q2 2026, against a consensus estimate of $1.5B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.